Mao K - Search Results

1

Fasudil inhibits prostate cancer-induced angiogenesis in vitro.

Chen W, Mao K, Hua-Huy T, Bei Y, Liu Z, Dinh-Xuan AT. Chen W, et al. Among authors: mao k. Oncol Rep. 2014 Dec;32(6):2795-802. doi: 10.3892/or.2014.3491. Epub 2014 Sep 17. Oncol Rep. 2014. PMID: 25333508

2

The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy.

Mao K, Camparo P, Badoual C, Peyromaure M, Delongchamps NB, Vieillefond A, Dinh-Xuan AT. Mao K, et al. Oncol Rep. 2008 Jan;19(1):171-5. Oncol Rep. 2008. PMID: 18097592

3

The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review).

Chen W, Mao K, Liu Z, Dinh-Xuan AT. Chen W, et al. Among authors: mao k. Oncol Lett. 2014 Nov;8(5):1907-1911. doi: 10.3892/ol.2014.2471. Epub 2014 Aug 21. Oncol Lett. 2014. PMID: 25289078 Free PMC article.

4

Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.

Peyromaure M, Badoual C, Camparo P, Grabar S, Goulvestre C, Fulla Y, Vieillefond A, Mao K, Dinh-Xuan AT. Peyromaure M, et al. Among authors: mao k. Oncol Rep. 2007 Jul;18(1):145-9. Oncol Rep. 2007. PMID: 17549360

5

High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation.

Chen W, Delongchamps NB, Mao K, Beuvon F, Peyromaure M, Liu Z, Dinh-Xuan AT. Chen W, et al. Among authors: mao k. Oncol Lett. 2016 Feb;11(2):1375-1381. doi: 10.3892/ol.2015.4070. Epub 2015 Dec 31. Oncol Lett. 2016. PMID: 26893746 Free PMC article.

6

Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).

Gong H, Zhou L, Khelfat L, Qiu G, Wang Y, Mao K, Chen W. Gong H, et al. Among authors: mao k. Med Sci Monit. 2019 Apr 26;25:3090-3099. doi: 10.12659/MSM.912098. Med Sci Monit. 2019. PMID: 31026254 Free PMC article.

7

The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.

Mao K, Badoual C, Camparo P, Delongchamps NB, Vieillefond A, Dinh-Xuan AT, Peyromaure M. Mao K, et al. Can J Urol. 2008 Oct;15(5):4257-62. Can J Urol. 2008. PMID: 18814815

8

A comparative study of prostate cancer detection and management in China and in France.

Peyromaure EM, Mao K, Sun Y, Xia S, Jiang N, Zhang S, Wang G, Liu Z, Debré B. Peyromaure EM, et al. Among authors: mao k. Can J Urol. 2009 Feb;16(1):4472-7. Can J Urol. 2009. PMID: 19222885

9

Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer.

Delongchamps NB, Mao K, Theng H, Zerbib M, Debré B, Peyromaure M. Delongchamps NB, et al. Among authors: mao k. Eur Urol. 2005 Dec;48(6):946-50. doi: 10.1016/j.eururo.2005.07.008. Epub 2005 Aug 2. Eur Urol. 2005. PMID: 16126325

10

Management of prostate cancer in China: a multicenter report of 6 institutions.

Peyromaure M, Debré B, Mao K, Zhang G, Wang Y, Sun Z, Xu D, Jiang J, Sun Y. Peyromaure M, et al. Among authors: mao k. J Urol. 2005 Nov;174(5):1794-7. doi: 10.1097/01.ju.0000176817.46279.93. J Urol. 2005. PMID: 16217289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

945 results

Search Page

Filters